Terms: = Endocrine gland cancer AND uPA
289 results:
1. Urine steroid metabolomics as a diagnostic tool in primary aldosteronism.
Prete A; Lang K; Pavlov D; Rhayem Y; Sitch AJ; Franke AS; Gilligan LC; Shackleton CHL; Hahner S; Quinkler M; Dekkers T; Deinum J; Reincke M; Beuschlein F; Biehl M; Arlt W
J Steroid Biochem Mol Biol; 2024 Mar; 237():106445. PubMed ID: 38104729
[TBL] [Abstract] [Full Text] [Related]
2. Validation of the Aldosteronoma Resolution Score as a Predictive Resolution Score of Hypertension After Unilateral Adrenalectomy for Primary Aldosteronism in a North-African Population.
Saadi A; Bedoui MA; Zaghbib S; Boussaffa H; Mokaddem S; Nacef IB; Ayed H; Bouzouita A; Derouiche A; Khiari K; Chakroun M; Slama RB
World J Surg; 2023 Nov; 47(11):2776-2783. PubMed ID: 37667066
[TBL] [Abstract] [Full Text] [Related]
3. Predictors of successful outcome after adrenalectomy for unilateral primary aldosteronism.
Saadi A; Bedoui MA; Zaghbib S; Boussaffa H; Mokaddem S; Nacef IB; Ayed H; Derouiche A; Khiari K; Chakroun M; Ben Slama R
Front Endocrinol (Lausanne); 2023; 14():1205988. PubMed ID: 37635962
[TBL] [Abstract] [Full Text] [Related]
4. Circulating tumor DNA in unresectable pancreatic cancer is a strong predictor of first-line treatment efficacy: The KRASCIPANC prospective study.
Evrard C; Ingrand P; Rochelle T; Martel M; Tachon G; Flores N; Randrian V; Ferru A; Haineaux PA; Goujon JM; Karayan-Tapon L; Tougeron D
Dig Liver Dis; 2023 Nov; 55(11):1562-1572. PubMed ID: 37308396
[TBL] [Abstract] [Full Text] [Related]
5. Diagnostic accuracy of using multiple cytokines to predict aldosterone-producing adenoma.
Qin F; Wen H; Zhong X; Pan Y; Lai X; Yang T; Huang J; Yu J; Li J
Sci Rep; 2023 Apr; 13(1):5745. PubMed ID: 37029172
[TBL] [Abstract] [Full Text] [Related]
6. ALG3 Promotes Peritoneal Metastasis of Ovarian cancer through Increasing Interaction of α1,3-mannosylated upaR and ADAM8.
Cui X; Pei X; Wang H; Feng P; Qin H; Liu S; Yan Q; Liu J
Cells; 2022 Oct; 11(19):. PubMed ID: 36231102
[TBL] [Abstract] [Full Text] [Related]
7. Cortisol-producing adenoma-related somatic mutations in unilateral primary aldosteronism with concurrent autonomous cortisol secretion: their prevalence and clinical characteristics.
Wu WC; Peng KY; Lu JY; Chan CK; Wang CY; Tseng FY; Yang WS; Lin YH; Lin PC; Chen TC; Huang KH; Chueh JS; Wu VC
Eur J Endocrinol; 2022 Oct; 187(4):519-530. PubMed ID: 35900323
[TBL] [Abstract] [Full Text] [Related]
8. In Vitro and In Vivo Effects of the Urokinase Plasminogen Activator Inhibitor WX-340 on Anaplastic Thyroid cancer Cell Lines.
Baldini E; Presutti D; Favoriti P; Santini S; Papoff G; Tuccilli C; Carletti R; Di Gioia C; Lori E; Ferent IC; Gagliardi F; Catania A; Pironi D; Tripodi D; D'Andrea V; Sorrenti S; Ruberti G; Ulisse S
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409084
[TBL] [Abstract] [Full Text] [Related]
9. Urokinase plasminogen activator induces epithelial-mesenchymal and metastasis of pancreatic cancer through plasmin/MMP14/TGF-β axis, which is inhibited by 4-acetyl-antroquinonol B treatment.
Wu CZ; Chu YC; Lai SW; Hsieh MS; Yadav VK; Fong IH; Deng L; Huang CC; Tzeng YM; Yeh CT; Chen JS
Phytomedicine; 2022 Jun; 100():154062. PubMed ID: 35366491
[TBL] [Abstract] [Full Text] [Related]
10. The Urokinase Plasminogen Activation System in Pancreatic cancer: Prospective Diagnostic and Therapeutic Targets.
Kumar AA; Buckley BJ; Ranson M
Biomolecules; 2022 Jan; 12(2):. PubMed ID: 35204653
[TBL] [Abstract] [Full Text] [Related]
11. Aldosterone-producing nodules and CYP11B1 signaling correlate in primary aldosteronism.
Lin JH; Peng KY; Kuo YP; Liu H; Tan CB; Lin YF; Chiu HW; Lin YH; Chen YM; Chueh JS; Wu VC
Endocr Relat Cancer; 2022 Jan; 29(2):59-69. PubMed ID: 34821221
[TBL] [Abstract] [Full Text] [Related]
12. Characterization of a mutated KCNJ5 gene, G387R, in unilateral primary aldosteronism.
Chueh JS; Peng KY; Wu VC; Wang SM; Chan CK; Chen YM; Ke YY; Pan CY; Liao HW
J Mol Endocrinol; 2021 Sep; 67(4):203-215. PubMed ID: 34463641
[TBL] [Abstract] [Full Text] [Related]
13. A Notch-Dependent Inflammatory Feedback Circuit between Macrophages and cancer Cells Regulates Pancreatic cancer Metastasis.
Geng Y; Fan J; Chen L; Zhang C; Qu C; Qian L; Chen K; Meng Z; Chen Z; Wang P
Cancer Res; 2021 Jan; 81(1):64-76. PubMed ID: 33172931
[TBL] [Abstract] [Full Text] [Related]
14. Nomogram-Based Preoperative Score for Predicting Clinical Outcome in Unilateral Primary Aldosteronism.
Yang Y; Williams TA; Song Y; Yang S; He W; Wang K; Cheng Q; Ma L; Luo T; Yang J; Reincke M; Burrello J; Li Q; Mulatero P; Hu J
J Clin Endocrinol Metab; 2020 Dec; 105(12):. PubMed ID: 32898224
[TBL] [Abstract] [Full Text] [Related]
15. Infiltration of T cells promotes the metastasis of ovarian cancer cells via the modulation of metastasis-related genes and PD-L1 expression.
Wang JJ; Siu MK; Jiang YX; Chan DW; Cheung AN; Ngan HY; Chan KK
Cancer Immunol Immunother; 2020 Nov; 69(11):2275-2289. PubMed ID: 32504248
[TBL] [Abstract] [Full Text] [Related]
16. Tazarotene-Induced Gene 1 (TIG1) Interacts with Serine Protease Inhibitor Kazal-Type 2 (SPINK2) to Inhibit Cellular Invasion of Testicular Carcinoma Cells.
Shyu RY; Wang CH; Wu CC; Wang LK; Chen ML; Kuo CY; Lee MC; Lin YY; Tsai FM
Biomed Res Int; 2019; 2019():6171065. PubMed ID: 31886233
[TBL] [Abstract] [Full Text] [Related]
17. Multiplex quantitative analysis of stroma-mediated cancer cell invasion, matrix remodeling, and drug response in a 3D co-culture model of pancreatic tumor spheroids and stellate cells.
Hwang HJ; Oh MS; Lee DW; Kuh HJ
J Exp Clin Cancer Res; 2019 Jun; 38(1):258. PubMed ID: 31200779
[TBL] [Abstract] [Full Text] [Related]
18. Estrogen-independent role of ERα in ovarian cancer progression induced by leptin/Ob-Rb axis.
Ghasemi A; Saeidi J; Mohtashami M; Hashemy SI
Mol Cell Biochem; 2019 Aug; 458(1-2):207-217. PubMed ID: 31077012
[TBL] [Abstract] [Full Text] [Related]
19. Curcumin attenuates hyperglycemia-driven EGF-induced invasive and migratory abilities of pancreatic cancer via suppression of the ERK and AKT pathways.
Li W; Wang Z; Xiao X; Han L; Wu Z; Ma Q; Cao L
Oncol Rep; 2019 Jan; 41(1):650-658. PubMed ID: 30542713
[TBL] [Abstract] [Full Text] [Related]
20. 6-Substituted Hexamethylene Amiloride (HMA) Derivatives as Potent and Selective Inhibitors of the Human Urokinase Plasminogen Activator for Use in cancer.
Buckley BJ; Aboelela A; Minaei E; Jiang LX; Xu Z; Ali U; Fildes K; Cheung CY; Cook SM; Johnson DC; Bachovchin DA; Cook GM; Apte M; Huang M; Ranson M; Kelso MJ
J Med Chem; 2018 Sep; 61(18):8299-8320. PubMed ID: 30130401
[TBL] [Abstract] [Full Text] [Related]
[Next]
